Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients - Concepedia

Concepedia

Publication | Closed Access

Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients

38

Citations

11

References

2023

Year

Réda Chebani, F. Lombart, G. Chaby, A. Dadban, S. Debarbieux, M. Viguier, S. Oro, Anne Pham‐Ledard, C. Bédane, C. Picard‐Dahan,

British Journal of Dermatology

Abstract

We report the largest series to date of BP treated by omalizumab and confirm its effectiveness and safety in this indication. Serum baseline level of anti-BP180-NC16A IgE may predict response to treatment.

References

	Year	Citations

Page 1